Fusion protein construction is a widely employed biochemical technique, especially when it comes to multi-component enzymes such as cytochrome P450s. Here we describe a novel method for generating fusion proteins with variable linker lengths, protein fusion with variable linker insertion (P-LinK), which was validated by fusing P450 cin monooxygenase (CinA) to the flavodoxin shuttle protein (CinC). CinC was fused to the C terminus of CinA through a series of 16 amino acid linkers of different lengths in a single experiment employing 3 PCR amplifications. Screening for 2-b-hydroxy-1,8-cineole production by CinA-CinC fusion proteins revealed that enzymatically active variants possessed linker lengths of more than 5 amino acids, reaching optimum enzyme activity at a linker length of 10 amino acids. Our P-LinK method not only minimizes experimental effort and significantly reduces time demands but also requires only a single cloning and transformation step in order to generate multiple linker variants (1 to 16 amino acids long), making the approach technically simple and robust.
Reports

METHOD SUMMARY
P-Link is a ligase and restriction site independent method for generating fusion proteins or protein domains with varied linker lengths. Efficient cloning is ensured by 12 nucleotide-long phosphorothioated sequences introduced by PCR, which are chemically cleaved in alkaline conditions in the presence of iodine and ethanol. Thus, single-stranded DNA overhangs of 12 nucleotides are generated that efficiently hybridize and ensure a robust construction of fusion proteins with varied linker lengths in a single cloning and transformation step. linker bet ween Pdx-PdR-P450 cam (19) . The oxidation of camphor was increased 30-fold using this approach, yielding a turnover number of 306 min -1 and a coupling efficiency of 99% when compared with the stoichiometric mixture of P450 cam /Pdx /PdR (19) . Recently, the reductase domain of P450Rhf from Rhodococcus strain NCIMB 9784 was reported to serve as a versatile redox partner in monooxygenase fusion proteins (e.g., with P450 cam from Pseudomonas putida, P450 bzo from a metagenome library, and P450 balk from Alcanivorax borkumensis). Increased product titers and turnover numbers were obtained with a 16 amino acid linker inserted between P450 cam and the reductase domain of P450Rhf in P450 cam -RhF constructs (16, 20) . Various studies on P450 BM3 monooxygenase (class CYP102A1)-a natural P450-reductase fusion proteinindicate that the linker separating the heme and the reductase domain does not adopt a regular secondary structure; it was therefore proposed that the length of the linker, and not its amino acid sequence, has a significant impact on the activity of fusion proteins (13, 18, 21, 22) . Construction of fusion proteins with variable linker length is usually done in a linear manner by performing individual PCRs for each linker length and subsequent cloning (e.g., with restriction enzymes and DNA ligase), resulting in a time consuming and cost inefficient effort.
Here we repor t a versatile and rapid method for generating fusion proteins with variable linker lengths from 1 to 16 amino acids. Our method does not require restriction enzymes and is, to the best of our knowledge, the first method for inserting multiple length linkers between two proteins in a single experiment. Linker fusion is achieved through the PLICing cloning technique, which is based on the use of phosphorothioate primers (23 
Reagents and solutions
The trace element solution contained: calcium chloride dihydrate (0.45 mM), zinc sulfate heptahydrate (0.65 mM), manganese sulfate monohydrate (0.6 mM), disodium EDTA (54 mM), ferric chloride hexahydrate (62 mM), copper sulfate pentahydrate (0.6 mM), and cobalt chloride (0.75 mM). The solution was sterilized by filtering (0.22 µm filter) and stored at 4°C until use.
T he iodine cleavage solution contained: iodine cleavage buffer (500 mM Tris, pH 9.0) and iodine (100 mM in 99% ethanol) in MilliQ water (final volume of 10 µL). The solution was stored at 4°C and used within 14 days.
Generation of CinA-CinC fusion protein constructs
The genes coding for P450 cin monooxygenase (cinA) and cindoxin (cinC) were cloned in the pALXtreme-1a vector (2.05 kb), which is a derivative of the commercially available pET-28a (+) vector (5.4 kb) (Novagen, Merck KGaA, Darmstadt, Germany). The lacI gene from the pET-28a (+) vector was integrated into the genome of E. coli BL21-Gold (DE3). This strain was named E. coli BL21-Gold (DE3) lacI Q1 and was used in combination with the pALXtreme-1a vector (24) . Primer sequences are detailed in Supplementary Table S2 . The cinA gene (1.5 kb) was amplified using phosphorothioated primers FA1 and RA1, whereas the cinC gene (471 bp) was amplified using phosphorothioated primers FC1 and RC1. The plasmid backbone pALXtreme-1a (vector size 2.3 kb) was amplified using phosphorothioated primers RP1 and FP1. The primers FA1 and RP1 introduced complementary phosphorothioated nucleotides at the 5´ and 3´ ends of the cinA gene and the plasmid backbone. Primers RA1 and FC1 introduced complementary phosphorothioated nucleotides at the 3´ and 5´ ends of cinA and cinC, respectively. Oligonucleotides RC1 and FP1 introduced complementary phosphorothioated nucleotides at the 5´ ends of cinC and the vector ( Figure 1B ).
PCRs were performed in a final volume of 50 µL containing 1× PfuS DNA polymerase buffer, 0.2 mM dNTP mix, 20 µM each forward and reverse primer, 1 U PfuS DNA polymerase, and 10 ng of template plasmid. The PCR protocol was: 98°C for 1 min; 20 cycles of 98°C for 30 s, 65°C for 30 s, and 72°C for 60 s (cinA), or 40 s (cinC), or 90 s (pALXterme-1a); followed by a final extension at 72°C for 5 min. The PCR products were digested with DpnI (10 U, 37°C for 4 h) and then purified using the QlAquick PCR Purification Kit. Subsequently, cleavage reactions were performed in a thermocycler (70°C for 5 min) in 3 separate tubes for cinA, cinC, and pALXtreme1a. Each tube contained cinA or cinC or pALXtreme-1a (0.6 pmol) in a volume of 4 µL, which was supplemented with 1 µL of iodine cleavage solution (23) . Next, cinA and cinC (0.2 pmol each) and pALXtreme-1a (0.12 pmol) were pooled and hybridized (through the generated 12 nucleotide single-stranded DNA overhangs) at room temperature for 10 min. The hybridization products were transformed into chemically competent E. coli BL-21 Gold(DE3) lacI Q1 cells as previously reported (25 Table S2 ), and 1 U PfuS DNA polymerase. The PCR cycling program was: 1 cycle (98°C for 1 min); 20 cycles (98°C for 30 s, touchdown to 56°C from 68°C in the initial 12 cycles, and then 56°C for the next 8 cycles; 72°C, 90 s); and a final elongation at 72°C for 5 min. The amplified PCR products were subjected to DpnI digestion (10 U, 37°C, overnight), subsequently purified using the QlAquick PCR Purification Kit, and eluted in 30 µL Milli-Q water. The purified PCR fragments containing the cinA-cinC fusion library with linker lengths from 1 to 5 amino acids (PCR i), linker lengths from 6 to 11 amino acids (PCR ii) or linker lengths from 12 to 16 amino acids (PCR iii) were separately cleaved by mixing 1 µL iodine cleavage solution with 4 µL purified DNA fragments of CinA-linker (1- lengths from 1 to 16 amino acids. A library of CinA-CinC fusion proteins with variable linker lengths from 1 to 16 was thus achieved with a single cloning step and a single transformation step. Transformants were picked and transferred into 96-well flat bottom microtiter plates (Greiner Bio-one GmbH, Frickenhausen, Germany) containing LB kan media (100 µL, 17 µM kanamycin) and incubated in microtiter plate shakers (37°C, 900 rpm, 70% humidity, 14-16 h) (Multitron II, Infors GmbH, Einsbach, Germany).
Protein expression and purification
The expression of the CinA-CinC fusion protein linker library, as well as the purification of CinA and the variants CinA-linker (6 -11) -CinC, was performed according to previously repor ted protocols for CinA (26) including minor modifications, which are described in detail in the Supplementary Material. E xpression of E. coli flavodoxin reductase (Fpr) was performed as previously reported, and purification was performed with modifications to the protocol of Hawkes et al. (27, 28) .
Activity assay and gas chromatographic analysis
Enzymatic activity of CinA-linker (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) -CinC fusion proteins was determined in a 96-well microtiter plate format using crude cell lysate and an automated thin layer chromatography (TLC) sampler for semi-quantification of 1,8-cineole hydroxylation. The product formation (2-b-hydroxy-1,8-cineole) by the CinA-Linker-CinC fusion proteins (1 µM) supplemented with Fpr (1 µM) and NADPH (0.4 mM) was quantified using gas chromatography (GC). The experimental details are available in the Supplementary Material.
Results and discussion
Enzymatically, P450 cin monooxygenase regioselectively hydroxylates 1,8-cineole to 2-b-hydroxy-1,8-cineole ( Figure 1A ), a compound used as an odorant and flavoring agent in cosmetics, food, and disinfectants. In addition, esters of 2-b-hydroxy-1,8-cineole have also been reported to have antimicrobial and bactericidal activities (26, 29, 30) . P450 cin requires as redox partners for hydroxylation a flavin adenine dinucleotide (FAD)-containing cindoxin reductase (CinB) and a flavin mononucleotide (FMN)-containing cindoxin (CinC). As a reduction equivalent, NADPH is used in the electron transfer chain from CinB -> CinC -> CinA (P450cin). CinB is usually replaced in activity measurements by the E. coli NADPH-ferredoxin (flavodoxin) reductase (Fpr), which is, in contrast to CinB, highly expressed in its active form in E. coli (26, 27, 31) . Figure 1 B and C show our strategy for the fusion of cinA and cinC, as well as the PCR steps employed for insertion of variable length linkers between cinA and cinC. cinA and cinC were amplified using primers that included a 12 nucleotide phosphorothioated sequence at the 5´ end that was complementary to the phosphorothioated sequence of vector primer. The three amplification fragments obtained were then hybridized, resulting in the direct fusion of cinA-cinC in the plasmid pALXtreme-1a ( Figure 1B) .
To generate the cinA-Linker (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) -cinC library, the fusion construct was amplified using reverse primers (RL1 to RL3) and a mixture of forward primers (FL1 to FL16) , which amplify the whole pALXtreme-1a-cinA-cinC construct (4.3 kb) generating 16 different constructs possessing linkers ranging in size from 1 to 16 amino acids. The overall length of each linker could be varied by altering the length of the forward primers (see Figure 1C and the Supplementary Material for more information on primer design).
Secondary structure calculations of the reported P450 BM3 linker (PSPST-DQSAKKVRKK A) showed a 62.5% probability of a-helix formation (32, 33) ; the last 8 amino acids of the P450 BM3 linker (AKKVRKKA) had an 82.5% probability of a-helix formation whereas the secondary structure formation probability of the first 8 amino acids (PSPSTDQS) was only 37.5% (Supplementary Table  S4 ). To avoid introducing a linker prone to secondary structure formation, the sequence of the first eight amino acids of P450-BM3 was selected for CinA-CinC linker generation. The sequence for the subsequent eight amino acids (PSTGDAVA) was chosen by analyzing frequently occurring sequences in natural fusion proteins that have no calculated secondary structure (34, 35) . Following structural considerations, the amino acid sequence for the full linker length of 16 amino acids between CinA and CinC was PSPSTDQSPSTGDAVA. The length and sequence of the linker was increased by one amino acid starting from proline (e.g., linker 5 = PSPST). Figure 1C details the methodology behind the construction of the linker proteins (PCRs subsets i, ii, and iii). To insert a linker with a length of 1-5 amino acids ( Figure 1C i) , a reverse primer (RL1) and a mixture of forward primers (FL1-FL5) is used. The RL1 primer includes a 34 bp sequence that is complementary to the 3´ end of cinA and 12 phosphorothioated nucleotides at the 5´ end. The FL1 primer contains a nucleotide sequence complementary to the first codon of the linker, flanked by a cinC specific sequence at the 3´ end. Similarly, primers FL2, FL3, FL4, and FL5 are designed to include nucleotide sequences encoding amino acids 2, 3, 4, and 5 of the linker. All forward primers (FL1-FL5) include a 12 phosphorothioated nucleotide sequence at the 5´ end complementary to the phosphorothioated sequence of the primer RL1.
For PCR subset ii, insertion of linkers 6-11 amino acids in length, the reverse primer RL2 was designed to include a sequence coding for linker amino acids 1 to 5 ( Figure 1C ii), and forward primers FL6-FL11 were employed using the same strategy as in PCR subset i to generate constructs with linker lengths of 6-11 amino acids. In PCR subset iii, the design of the primers to insert linkers with a length of 12-16 amino acids employs the reverse primer RL3, coding for linker amino acids 1 to 10, and primers FL12-FL16 including the sequence coding for linker amino acids 12-16 ( Figure 1C iii) .
In total, 270 CinA-Linker (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) -CinC variants were screened for 2-b-hydroxy-1,8-cineole production in 96-well microtiter plates using an automated TLC sampler in order to semi-quantify the hydroxylation product (2-b-hydroxy-1,8-cineole). The 32 most active variants were then subjected to GC analysis to quantify 2-b-hydroxy-1,8-cineole formation.
The direct fusion of CinA-CinC (i.e., no linker) showed no measurable conversion of 1,8- Figure S1 ).
Despite the generation and identification of an active CinA-CinC fusion protein, an equimolar mix of free CinA, CinC and Fpr (1 µM) shows higher product formation (315 µM compared with 176 µM for a 10 amino acid linker fusion protein) (Supplementary Material, Supplementary  Table S3 ). In order to keep the systems comparable, an equimolar ratio was used instead of the optimal ratio of 1:8:2 for CinA, CinC, and Fpr (27) .
Structural studies of linker regions of fusion proteins are very challenging. The length, flexibility, and sequence of amino acids can have dramatic effects on the activity and structural stability of the fused domains. Given their high flexibility, loops tend to have an ambiguous conformation in crystal structures, and their behavior and interactions with the fused domains are difficult to predict (36) . Therefore, optimal linker lengths for protein fusion are difficult to determine in a rational manner, and a single length is usually probed and used for generating fusion proteins, dramatically reducing their success rate.
An alternative to our P-Link methodology would be using methods based on overlap extension PCR. However, P-Link can be expanded to vary linker sequence or to include different vector backbones in a single tube experiment, thereby providing more alternatives for expression of fusion constructs. Additionally, P-link is a technically less laborious method in terms of the number of PCR reactions (3 versus 16) and the transformations required (e.g., 16 linker constructs in 1 transformation instead of 16 transformations). Another potential advantage of this method is the expansion of P-Link to fuse three and four multi-component systems at once, which is likely much less efficient in the case of overlap extension PCR (37) , not to mention that varied amino acid sequences could be incorporated within the linkers (e.g., two positions with NNK codons) to explore or tune flexibility and thereby increase activity. It is also crucial to note that the advantage of overlap extension PCR methods when screening only a few clones is lost if diversity is generated on the protein level in order to optimize the flexibility of linkers.
Although the fusion protein generated in this study showed lower activity compared with an equimolar mix of its components, the use of fusion proteins simplifies the multicomponent system on a genetic level and enables its use in protein engineering applications. The latter can be used to obtain fusion protein variants with improved activity or with non-natural enzymatic properties In summary, our phosphothioatebased P-LinK method enables the generation of libraries of fusion proteins possessing multiple linker lengths. Generation of fusion proteins and insertion of inter-domain linkers of variable length can be achieved in a single experiment and then screened for optimal properties, such as protein expression or enzymatic activity. A fusion protein library of fused P450 cin monooxygenase (CinA) and cindoxin (CinC) with a linker length ranging from 1 to 16 amino acids was generated, and an optimal linker length was determined. It is likely that P-LinK can be expanded iteratively to at least 
